Major Depressive Disorder

The treatment is approved as either a monotherapy or an adjunctive therapy with either lithium or valproate.

Copy number variations were broadly associated with an increased risk of autism spectrum disorder and ADHD.

Students with IBS were also linked to depression and anxiety symptoms.

There was a correlation between anxiety scores and COVID-19 cases.

Gastrointestinal symptoms were significantly linked to severe symptoms of depression and anxiety.

Relapse occurred in 39% of the maintenance group, compared to 56% in the discontinuation group.

Taste scores were significantly correlated with depression scores for both patients with irritable bowel syndrome and functional constipation.

Anxiety, social support, mother-infant relationship, and infant temperament all improved after a 1-day CBT-based workshop.

There are several clinical trials testing psychedelics as a treatment option for psychiatric disorders.

Depression is the leading cause of disability in the US.

There are a number of ongoing clinical trials testing psychedelics as a treatment for psychiatric disorders.

Patients with severe mental health issues often are linked to health inequalities that contribute to a shorter life expectancy than the general population.

Developed by BrainsWay, the new device has been shown to decrease anxiety symptoms in adult patients with anxious depression.

There has been a lot of variance in mental health studies during the COVID-19 pandemic.

Higher depressive and manic (symptoms were associated with lower GAF, most strongly among the older participants.

Severe mental disorders had the highest odds ratios for the risk of mortality.

For only reward learning, anhedonia was associated with model-derived learning parameters and neural learning signals.

Younger age and individuals who work more than 41 hours per week were associated with more prevalent mental health symptoms.

Dr. Robert Baillieu discusses how the COVID-19 pandemic has specifically impacted patients dealing with addiction problems.

The treatment was well-tolerated with a safety profile consistent with previous clinical trials.

Lamotrigine is currently being used as a maintenance therapy for bipolar disorder.

Baseline eGFR and increasing age were good predictors of eGFR.

REL-1017 was more effective when administered earlier rather than later.

The higher levels of visits were mostly maintained throughout the pandemic.

The reduction in heavy drinking in individuals between 18-25 years old is likely due to government restrictions on social gatherings.